SSPL WEALTH PVT LTD

Wednesday 01 May, 2024 06:35 AM

Exide Inds gains as Q4 PAT jumps 36% YoY to Rs 284 cr IOCL slips after Q4 PAT slumps 52% YoY to Rs 4,838 cr Newgen Software Tech hits lifetime high as Q4 PAT climbs 54% QoQ P&G Hygiene slips as Q3 PAT slides 6% YoY to Rs 154 cr Patel Engineering Ltd leads losers in 'A' group REC spurts on recording good Q4 performance Shiva Mills Ltd leads losers in 'B' group Sprayking soars after order win Volumes soar at SBFC Finance Ltd counter Metal shares slide Information Technology stocks slide KFin Tech hits record high after Q4 PAT jumps 30% YoY Spandana Sphoorty records 22% YoY growth in Q4 PAT; AUM at Rs 11,973 crore Granules India gains after receiving US FDA nod for gout medicine APL Apollo Tubes Ltd rises for third straight session

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Piramal Pharma rises after USA facility clears USFDA inspection

18-Apr-24 09:40 Hrs IST

Earlier in February 2024, the US Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAI) inspection of the company?s Riverview (USA) facility from 29th January 2024 to 6th February 2024.

On conclusion of the inspection, a Form-483 was issued with 3 observations. The observations were classified under VAI (Voluntary Action Indicated).

Piramal Pharma is a pharmaceutical company that manufactures and develops a wide range of pharmaceutical solutions to reduce diseases. Piramal Pharma serves customers worldwide.

The pharmaceutical company reported a consolidated net profit of Rs 10.11 crore in Q3 FY24 as compared with net loss of Rs 90.18 crore recorded in Q3 FY23. Revenue from operations rose by 14.1% year-on-year to Rs 1,958.57 crore in Q3 FY24.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 32277171

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)